Tag: mid-cap
Willdan Stock Analysis: Buy or Sell? Valuation, Margins, Growth & Leverage
Willdan Group (WLDN) is rated Hold as growth improves but the stock already reflects much of the progress. Revenue and EBITDA have strengthened, yet execution risk remains if operating margin slips below 10% and the current valuation stops looking forgiving.
Century Aluminum Stock Analysis: Buy or Sell? Valuation, Cash Flow & Margins
Century Aluminum (CENX) is rated Hold as earnings have improved, but cash conversion remains weak. The stock looks reasonably levered and operationally stronger, yet negative free cash flow keeps the valuation from looking compelling.
SM Energy Stock Analysis: Buy or Sell? Valuation, Leverage & FCF
SM Energy (SM) is a Buy, backed by $1.5B in trailing free cash flow and a 15.5% FCF yield. The stock looks undervalued at 5.1x EV/EBITDA, but leverage and tight liquidity remain the key risks.
AMN Healthcare Stock Analysis: Buy or Sell? Valuation, Cash Flow & Client Concentration
AMN Healthcare Services, Inc. (AMN) is rated Hold because cash generation is solid, but earnings remain uneven and the valuation is not cheap. Strong free cash flow supports the case, while Kaiser concentration and a demanding forward P/E keep the risk-reward balanced.
Ingredion Stock Analysis: Buy or Sell? Valuation, Margins & Free Cash Flow
Ingredion (INGR) is rated Hold because its balance sheet and cash generation are strong, but growth is too modest to justify a rerating. Valuation looks fair to slightly rich, while earnings momentum remains uneven and is the key thing investors need to watch.
Generac Holdings Stock Analysis: Buy or Sell? Valuation, Free Cash Flow & Leverage
Generac Holdings (GNRC) is rated Hold as valuation already discounts a recovery, while cash conversion remains modest. Strong free cash flow and manageable leverage support the case, but one-sided insider selling and a fair-to-slightly-rich multiple keep the stock in wait-and-see territory.
HubSpot Stock Analysis: Buy or Sell? Valuation, Margins & FCF
HubSpot (HUBS) is rated Hold as strong revenue growth is being offset by thin operating margins. The stock looks fairly valued on EV/revenue, but the path to a higher rating depends on better operating leverage and sustained growth.
Ironwood Pharmaceuticals Stock Analysis: Buy or Sell? FCF, Valuation, Pipeline
Ironwood Pharmaceuticals (IRWD) is rated Hold as LINZESS continues to generate real free cash flow, but apraglutide has faced delays and the stock already reflects much of the progress. The main debate is whether cash generation can offset LINZESS concentration and the 2027 Medicare price reset.
StoneX Stock Analysis: Buy or Sell? Leverage, Margins & Valuation
StoneX Group Inc. (SNEX) is rated Hold as growth remains solid but leverage and thin margins limit upside. The stock is not expensive on forward earnings, yet debt/equity near 823.5% leaves little room for disappointment.
Flowserve Stock Analysis: Buy or Sell? Valuation, Debt, Free Cash Flow
Flowserve Corporation (FLS) is rated Hold as its installed-base service network supports cash generation, but revenue remains flat to down. The stock looks fairly valued, while 2.2x net debt/EBITDA keeps leverage and backlog conversion on watch.